Johnson & Johnson (JNJ)
204.99
+5.03
(+2.52%)
USD |
NYSE |
Dec 10, 14:01
Johnson & Johnson Free Cash Flow: 20.46B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Gilead Sciences, Inc. | 9.162B |
| Eli Lilly & Co. | 6.436B |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Protagonist Therapeutics, Inc. | 63.71M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 9.169B |
| Cash from Investing (Quarterly) | -542.00M |
| Cash from Financing (Quarterly) | -8.927B |
| Free Cash Flow Per Share (Quarterly) | 3.292 |
| Free Cash Flow to Equity (Quarterly) | 12.96B |
| Free Cash Flow to Firm (Quarterly) | 8.255B |
| Free Cash Flow Yield | 4.12% |